India has granted Pfizer a patent for its powerful pneumonia vaccine Prevenar 13, in a blow to some health groups that said this would put the treatment out of reach of thousands in poorer nations. The decision by India’s patent office bars other companies from making cheaper copies of the vaccine and allows Pfizer to exclusively sell it in India until 2026. It’s a big victory for the U S drugmaker in a market that has the world’s largest number of pneumonia cases, a lung disease. Tuesday’s decision also has international implications, as several ...
India grants Pfizer patent on pneumonia vaccine
It's a big victory for the US drugmaker in a market that has largest number of pneumonia cases